[Congressional Record Volume 163, Number 7 (Wednesday, January 11, 2017)]
[Senate]
[Page S287]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 142. Ms. WARREN (for herself and Mr. Casey) submitted an amendment 
intended to be proposed by her to the concurrent resolution S. Con. 
Res. 3, setting forth the congressional budget for the United States 
Government for fiscal year 2017 and setting forth the appropriate 
budgetary levels for fiscal years 2018 through 2026; which was ordered 
to lie on the table; as follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO PROVIDING 
                   FUNDING TO NIH AND FDA TO SUPPORT BIOMEDICAL 
                   INNOVATION RESEARCH.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to establishing a Biomedical Innovation Fund that 
     will support $5,000,000,000 in annual supplementary funds to 
     the National Institutes of Health and the Food and Drug 
     Administration to support biomedical innovation research by 
     the amounts provided in such legislation for those purposes, 
     provided that such legislation would not increase the deficit 
     over either the period of the total of fiscal years 2017 
     through 2021 or the period of the total of fiscal years 2017 
     through 2026.
                                 ______